What's happening
This bill requires health insurance policies in New York to cover optional anesthesia for certain contraceptive and menstrual health procedures.
Why it matters
Expands access to pain management. By requiring insurance to cover optional anesthesia for procedures like IUD insertion, ablation, and colposcopy, the bill addresses a significant barrier to care for people who experience pain during these common reproductive and menstrual health procedures.
Reduces out-of-pocket costs and health disparities. Optional anesthesia is often not covered, forcing patients to pay out of pocket or forgo pain relief. This change particularly helps low-income individuals and those whose pain has previously been dismissed or undertreated, promoting more equitable care.
Recognizes menstrual health as essential. By explicitly including "menstrual health procedures" in insurance mandates, the bill elevates their importance alongside contraception, signaling broader recognition of menstrual health as a legitimate and necessary aspect of medical care.
May influence provider and insurance practices. Insurance coverage requirements could lead to more standardized offerings of anesthesia for relevant procedures and could encourage providers to routinely discuss pain management options, improving overall patient experience and informed consent.
Albany, before your first meeting.
Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.
Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.
Who cares
Patients undergoing vaginal, cervical or uterine procedures
The bill would require coverage of optional anesthesia for procedures including IUD insertion, colposcopy, ablation and loop electrosurgical excision.
Health insurers
The bill would expand coverage requirements under the affected policies and contracts to include FDA-approved menstrual health procedures and optional anesthesia for specified types of procedures.
Gynecologists and anesthesia providers
The bill would require insurance coverage for optional anesthesia used in vaginal, cervical and uterine medical procedures they perform or support.
Headline styles
Cover Anesthesia for Reproductive Procedures
Plain English, a few words. Used as the page title.
Sponsors
2 Co-sponsors
History
- Referred to insurance
Companion bill
The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.
Cover Anesthesia for Women’s Procedures
In Assembly Committee · Insurance · Sponsor Tony Simone
Full text
4 pagesUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗
STATE OF NEW YORK
8786
IN SENATE
March 11, 2024
Introduced by Sen. MAY -- read twice and ordered printed, and when printed to be committed to the Committee on Insurance
AN ACT to amend the insurance law, in relation to requiring health insurance policies to include coverage of optional anesthesia for certain contraceptive and menstrual health procedures
The People of the State of New York, represented in Senate and Assembly, do enact as follows:
Section 1. Clause (v) of subparagraph (E) of paragraph 17 of subsection (i) of section 3216 of the insurance law, as amended by section 3 of part M of chapter 57 of the laws of 2019, is amended to read as follows:
(v) all FDA-approved menstrual health procedures and contraceptive drugs, devices, and other products, including all over-the-counter contraceptive drugs, devices, and products as prescribed or as otherwise authorized under state or federal law; voluntary sterilization procedures pursuant to 42 U.S.C. 18022 and identified in the comprehensive guidelines supported by the health resources and services administration and thereby incorporated in the essential health benefits benchmark plan; patient education and counseling on contraception; and follow-up services related to the drugs, devices, products, and procedures covered under this clause, including, but not limited to, management of side effects, counseling for continued adherence, and device insertion and removal. Except as otherwise authorized under this clause, a contract shall not impose any restrictions or delays on the coverage required under this clause. However, where the FDA has approved one or more therapeutic and pharmaceutical equivalent, as defined by the FDA, versions of a contraceptive drug, device, or product, a contract is not required to include all such therapeutic and pharmaceutical equivalent versions in its formulary, so long as at least one is included and covered without cost-sharing and in accordance with this clause. If the covered therapeutic and pharmaceutical equivalent versions of a drug, device, or product are not available or are deemed medically inadvisable a contract shall provide coverage for an alternate therapeutic and pharmaceutical equivalent version of the contraceptive drug, device, or
EXPLANATION--Matter in italics (underscored) is new; matter in brackets
[ ] is old law to be omitted.
LBD14820-01-4
product without cost-sharing. (a) This coverage shall include emergency contraception without cost sharing when provided pursuant to a prescription, or order under section sixty-eight hundred thirty-one of the education law or when lawfully provided over-the-counter. (b) If the attending health care provider, in his or her reasonable professional judgment, determines that the use of a non-covered therapeutic or pharmaceutical equivalent of a drug, device, or product is warranted, the health care provider's determination shall be final. The superintendent shall promulgate regulations establishing a process, including timeframes, for an insured, an insured's designee or an insured's health care provider to request coverage of a non-covered contraceptive drug, device, or product. Such regulations shall include a requirement that insurers use an exception form that shall meet criteria established by the superintendent. (c) This coverage must allow for the dispensing of up to twelve months worth of a contraceptive at one time. (d) This coverage shall include optional anesthesia for vaginal, cervical, and uterine medical procedures, including, but not limited to, loop electrosurgical excision procedure, colposcopy, ablation, and intrauterine device insertion. (e) For the purposes of this clause, "over-the-counter contraceptive products" shall mean those products provided for in comprehensive guidelines supported by the health resources and services administration as of January twenty-first, two thousand nineteen.
§ 2. Subparagraph (A) of paragraph 16 of subsection (l) of section 3221 of the insurance law, as amended by section 1 of part M of chapter 57 of the laws of 2019, is amended to read as follows:
(A) Every group or blanket policy that provides medical, major medical, or similar comprehensive type coverage that is issued, amended, renewed, effective or delivered on or after January first, two thousand twenty, shall provide coverage for all of the following services, menstrual health procedures, and contraceptive methods:
(1) All FDA-approved menstrual health procedures and contraceptive drugs, devices, and other products. This includes all FDA-approved over-the-counter contraceptive drugs, devices, and products as prescribed or as otherwise authorized under state or federal law. The following applies to this coverage:
(a) where the FDA has approved one or more therapeutic and pharmaceutical equivalent, as defined by the FDA, versions of a contraceptive drug, device, or product, a group or blanket policy is not required to include all such therapeutic and pharmaceutical equivalent versions in its formulary, so long as at least one is included and covered without cost-sharing and in accordance with this paragraph;
(b) if the covered therapeutic and pharmaceutical equivalent versions of a drug, device, or product are not available or are deemed medically inadvisable a group or blanket policy shall provide coverage for an alternate therapeutic and pharmaceutical equivalent version of the contraceptive drug, device, or product without cost-sharing. If the attending health care provider, in his or her reasonable professional judgment, determines that the use of a non-covered therapeutic or pharmaceutical equivalent of a drug, device, or product is warranted, the health care provider's determination shall be final. The superintendent shall promulgate regulations establishing a process, including timeframes, for an insured, an insured's designee or an insured's health care provider to request coverage of a non-covered contraceptive drug, device, or product. Such regulations shall include a requirement that insurers use an exception form that shall meet criteria established by the superintendent;
(c) this coverage shall include emergency contraception without costsharing when provided pursuant to a prescription or order under section sixty-eight hundred thirty-one of the education law or when lawfully provided over the counter; [and]
(d) this coverage must allow for the dispensing of up to twelve months worth of a contraceptive at one time; and
(e) this coverage shall include optional anesthesia for vaginal, cervical, and uterine medical procedures, including, but not limited to, loop electrosurgical excision procedure, colposcopy, ablation, and intrauterine device insertion;
(2) Voluntary sterilization procedures pursuant to 42 U.S.C. 18022 and identified in the comprehensive guidelines supported by the health resources and services administration and thereby incorporated in the essential health benefits benchmark plan;
(3) Patient education and counseling on contraception; and
(4) Follow-up services related to the drugs, devices, products, and procedures covered under this paragraph, including, but not limited to, management of side effects, counseling for continued adherence, and device insertion and removal.
§ 3. The opening paragraph and subparagraph (A) of paragraph 1 of subsection (cc) of section 4303 of the insurance law, as amended by section 2 of part M of chapter 57 of the laws of 2019, are amended to read as follows:
Every contract that provides medical, major medical, or similar comprehensive type coverage that is issued, amended, renewed, effective or delivered on or after January first, two thousand twenty, shall provide coverage for all of the following services, menstrual health procedures, and contraceptive methods:
(A) All FDA-approved menstrual health procedures and contraceptive drugs, devices, and other products. This includes all FDA-approved over-the-counter contraceptive drugs, devices, and products as prescribed or as otherwise authorized under state or federal law. The following applies to this coverage:
(i) where the FDA has approved one or more therapeutic and pharmaceutical equivalent, as defined by the FDA, versions of a contraceptive drug, device, or product, a contract is not required to include all such therapeutic and pharmaceutical equivalent versions in its formulary, so long as at least one is included and covered without cost-sharing and in accordance with this subsection;
(ii) if the covered therapeutic and pharmaceutical equivalent versions of a drug, device, or product are not available or are deemed medically inadvisable a contract shall provide coverage for an alternate therapeutic and pharmaceutical equivalent version of the contraceptive drug, device, or product without cost-sharing. If the attending health care provider, in his or her reasonable professional judgment, determines that the use of a non-covered therapeutic or pharmaceutical equivalent of a drug, device, or product is warranted, the health care provider's determination shall be final. The superintendent shall promulgate regulations establishing a process, including timeframes, for an insured, an insured's designee or an insured's health care provider to request coverage of a non-covered contraceptive drug, device, or product. Such regulations shall include a requirement that insurers use an exception form that shall meet criteria established by the superintendent;
(iii) this coverage shall include emergency contraception without cost-sharing when provided pursuant to a prescription or order under section sixty-eight hundred thirty-one of the education law or when lawfully provided over the counter; [and]
(iv) this coverage must allow for the dispensing of up to twelve months worth of a contraceptive at one time; and
(v) this coverage shall include optional anesthesia for vaginal, cervical, and uterine medical procedures, including, but not limited to, loop electrosurgical excision procedure, colposcopy, ablation, and intrauterine device insertion;
§ 4. This act shall take effect immediately.
Reflowed for reading: line numbers and page breaks removed. Cite the official text.
Sponsor's memo
Title of bill
An act to amend the insurance law, in relation to requiring health insurance policies to include coverage of optional anesthesia for certain contraceptive and menstrual health procedures
Purpose
To allow individuals seeking reproductive healthcare to receive local or general anesthetic from their medical providers, covered by their health insurance policies
Summary of specific provisions
Section 1 amends Section 3216 of the insurance law to add menstrual health procedures to the list of treatments included in coverage of anesthesia.
Read the full memo (622 words)
Section 2 amends Section 3221 of the insurance law to add menstrual health procedures to the list of treatments included in coverage of anesthesia.
Section 3 amends Section 4303 of the insurance law to add menstrual health procedures to the list of treatments included in coverage of anesthesia.
Section 4 establishes the effective date of the bill.
Justification
This bill would require health insurance to cover local or general anes- thesia for people undergoing medical procedures including but not limit- ed to IUD insertion, loop electrosurgical excision procedure, colposco- py, and ablation. Not only would this allow patients more flexibility in their surgery, it would further New York's commitment to accessible reproductive healthcare.
Pain faced by women, and women of color especially, has been underesti- mated and ignored. Pain has been considered a "necessary evil" in the process of regulating menstrual health and childbirth, faced by people of all ages and backgrounds. One of the most effective methods of birth control, an intrauterine device (IUD), estimated to be used by around 14% of women ages 15 to 44, roughly 10 million people, can last from 3 to 12 years and can also be used to treat heavy periods and the side effects that they cause. Though this is a fairly common procedure, according to a 2014 study in the medical journal Contraception, provid- ers routinely underestimate the pain that comes with the insertion of an IUD. Vasovagal responses to the insertion of this device are also common, leading individuals seeking treatment to feel dizzy, nauseated, and occasionally pass out. When an IUD insertion goes perfectly, side effects include pain and heavy cramping, and many people who opt for this procedure receive no pain management from their physicians. Treat- ment is inconsistent across the board, with reports of some individuals receiving local anesthetic, or being advised to take mifepristone before the procedure.
While a 2016 study of people who had never given birth before in the Journal of Family Planning and Reproductive Healthcare showed that 83% of study participants were very happy with their IUD and 75% of partic- ipants said that the insertion process went 'very well,' 78% reported insertion pain as moderate to severe. 46% of participants experienced vasovagal symptoms. One does not need to look very far to come across stories of people who have had an IUD insertion, and have described it as a "deep biological sense that something in your body that should not be messed with is being aggravated" and "a pain level that gives a glimpse of childbirth." While other procedures are unthinkable without anesthetic - wisdom teeth excision, cystoscopies, colonoscopies - IUD insertions are similarly invasive. Understandably, some individuals will opt for anesthesia when undergoing this procedure, but anesthesia isn't covered for this procedure across the board. Anesthesia can cost $500 to $3,500 out-of-pocket, leaving it inaccessible to people who would benefit from the use of it during a procedure. Other procedures, like an endometrial ablation, where a medical professional scrapes out the interior lining of the uterus, and a colposcopy, which is a cervical cancer test, are invasive, intimate procedures that warrant the use of anesthesia.
Legislative history
New bill
Fiscal implications
Subject to appropriations
Effective date
Immediately
Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.